| Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer U Malapelle, R Sirera, E Jantus-Lewintre, P Reclusa, S Calabuig-Fariñas, ... Expert review of molecular diagnostics 17 (3), 209-215, 2017 | 176 | 2017 |
| Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients U Malapelle, C Mayo de-Las-Casas, D Rocco, M Garzon, P Pisapia, ... British Journal of Cancer 116 (6), 802-810, 2017 | 125 | 2017 |
| Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients U Malapelle, P Pisapia, D Rocco, R Smeraglio, M di Spirito, C Bellevicine, ... Translational lung cancer research 5 (5), 505, 2016 | 111 | 2016 |
| The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal V Gristina, U Malapelle, A Galvano, P Pisapia, F Pepe, C Rolfo, S Tortorici, ... Cancer Treatment Reviews 85, 101994, 2020 | 109 | 2020 |
| Liquid biopsy and lung cancer P Pisapia, U Malapelle, G Troncone Acta cytologica 63 (6), 489-496, 2019 | 104 | 2019 |
| The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review … A Galvano, V Gristina, U Malapelle, P Pisapia, F Pepe, N Barraco, ... ESMO open 6 (3), 100124, 2021 | 90 | 2021 |
| Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases U Malapelle, P Pisapia, R Sgariglia, E Vigliar, M Biglietto, C Carlomagno, ... Journal of clinical pathology 69 (9), 767-771, 2016 | 87 | 2016 |
| How to prepare cytological samples for molecular testing C Bellevicine, U Malapelle, E Vigliar, P Pisapia, G Vita, G Troncone Journal of clinical pathology 70 (10), 819-826, 2017 | 83 | 2017 |
| Next generation sequencing and genetic alterations in squamous cell lung carcinoma: where are we today? A Friedlaender, G Banna, U Malapelle, P Pisapia, A Addeo Frontiers in oncology 9, 166, 2019 | 77 | 2019 |
| Global impact of the COVID‐19 pandemic on cytopathology practice: results from an international survey of laboratories in 23 countries E Vigliar, R Cepurnaite, E Alcaraz‐Mateos, SZ Ali, ZW Baloch, ... Cancer cytopathology 128 (12), 885-894, 2020 | 60 | 2020 |
| Consistency and reproducibility of next‐generation sequencing and other multigene mutational assays: a worldwide ring trial study on quantitative cytological molecular … U Malapelle, C Mayo‐de‐Las‐Casas, MA Molina‐Vila, R Rosell, S Savic, ... Cancer cytopathology 125 (8), 615-626, 2017 | 60 | 2017 |
| Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of … C Bellevicine, I Migliatico, R Sgariglia, M Nacchio, E Vigliar, P Pisapia, ... Cancer cytopathology 128 (2), 107-118, 2020 | 59 | 2020 |
| Cytopathologists can reliably perform ultrasound‐guided thyroid fine needle aspiration: a 1‐year audit on 3715 consecutive cases C Bellevicine, E Vigliar, U Malapelle, P Pisapia, G Conzo, B Biondi, ... Cytopathology 27 (2), 115-121, 2016 | 58 | 2016 |
| Liquid biopsy in prostate cancer management—Current challenges and future perspectives F Crocetto, G Russo, E Di Zazzo, P Pisapia, BF Mirto, A Palmieri, F Pepe, ... Cancers 14 (13), 3272, 2022 | 56 | 2022 |
| EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay C De Luca, G Gragnano, P Pisapia, E Vigliar, U Malapelle, C Bellevicine, ... Journal of clinical pathology 70 (4), 295-300, 2017 | 54 | 2017 |
| KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting M Nacchio, R Sgariglia, V Gristina, P Pisapia, F Pepe, C De Luca, ... Journal of thoracic disease 12 (7), 3836, 2020 | 53 | 2020 |
| Patients selection for immunotherapy in solid tumors: overcome the naïve vision of a single biomarker D Signorelli, P Giannatempo, G Grazia, MM Aiello, F Bertolini, A Mirabile, ... BioMed research international 2019, 2019 | 52 | 2019 |
| ALK and ROS1 testing on lung cancer cytologic samples: perspectives P Pisapia, MD Lozano, E Vigliar, C Bellevicine, F Pepe, U Malapelle, ... Cancer Cytopathology 125 (11), 817-830, 2017 | 51 | 2017 |
| Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: the KWAY Italian multicenter cost evaluation study P Pisapia, F Pepe, A Baggi, M Barberis, A Galvano, V Gristina, F Mastrilli, ... Critical Reviews in Oncology/hematology 169, 103525, 2022 | 42 | 2022 |
| Tumor mutational burden on cytological samples: a pilot study F Pepe, P Pisapia, V Gristina, D Rocco, M Micheli, P Micheli, A Iaccarino, ... Cancer cytopathology 129 (6), 460-467, 2021 | 42 | 2021 |
